[HTML][HTML] SARS-CoV-2 vaccines: the advantage of mucosal vaccine delivery and local immunity

J Tobias, P Steinberger, J Wilkinson, G Klais, M Kundi… - Vaccines, 2024 - mdpi.com
Immunity against respiratory pathogens is often short-term, and, consequently, there is an
unmet need for the effective prevention of such infections. One such infectious disease is …

Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection

AG Abril, J Alejandre, A Mariscal, L Alserawan… - Scientific reports, 2024 - nature.com
Humoral immunity in COVID-19 includes antibodies (Abs) targeting spike (S) and
nucleocapsid (N) SARS-CoV-2 proteins. Antibody levels are known to correlate with disease …

Importance, applications and features of assays measuring SARS-CoV-2 neutralizing antibodies

P Gattinger, A Ohradanova-Repic… - International Journal of …, 2023 - mdpi.com
More than three years ago, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2) caused the unforeseen COVID-19 pandemic with millions of deaths. In the …

Anti‐spike IgG antibody kinetics following the second and third doses of BNT162b2 vaccine in nursing home residents

H Jeulin, C Labat, K Duarte, S Toupance… - Journal of the …, 2022 - Wiley Online Library
Background Duration of post‐vaccination protection against COVID‐19 in nursing home
(NH) residents is a critical issue. The objective of this study was to estimate the duration of …

Why Should Vaccines against Respiratory Diseases Go Mucosal? B Cell Epitope-Based Vaccines against SARS-CoV-2

J Tobias, P Steinberger, J Wilkinson, G Klais, M Kundi… - 2024 - preprints.org
Immunity against respiratory pathogens is often short-term, and consequently there is an
unmet need for effective prevention of such infections. One such infectious disease is COVID …